Does Antagonism at 5-HT 2A Receptors Potentiate D2 Blockade-Induced Disruption of Conditioned Avoidance Response?

Jun Gao, Yujing Huang, Ming Li

Research output: Contribution to journalArticle

Abstract

Existing evidence in the literature shows that antagonism at 5-HT 2A receptors potentiates D2 antagonisminduced disruption of conditioned avoidance response (CAR), a behavioral index of antipsychotic activity, suggesting that combining 5-HT 2A antagonism with D2 antagonism may confer an enhanced antipsychotic effect. The present study reexamined this issue and further investigated other behavioral effects of drug- drug interaction, mainly the conditioned drug effect (via drug- drug conditioning) and 5-HT 2A antagonism's modulation on antipsychotic-induced sensitization (an enhanced avoidance disruption). Well-trained adult male Sprague-Dawley rats were first repeatedly tested for 7 days under haloperidol (HAL; 0.05 mg/kg, subcutaneous [sc], a typical antipsychotic drug with potent D2 antagonism), MDL100907 (0.5 and 1.0 mg/kg, sc, a selective 5-HT 2A antagonist), combined MDL100907 and HAL, or vehicle control, followed by one challenge test under MDL100907 (0.5 mg/kg) to assess the conditioned drug effect and one challenge test under HAL (0.025 mg/kg) to assess HAL sensitization. Results showed that MDL100907 by itself had no effect on CAR. Importantly, MDL100907 treatment did little to alter the acute and sensitized effects of HAL-induced (0.05 mg/kg, sc) suppression of CAR under various treatment conditions. Repeated pairing of MDL100907 (1.0 mg/kg) with HAL rendered MDL100907 itself to exhibit an "acquired" CAR disruptive effect through a drug- drug conditioning process. These results do not support the notion that 5-HT 2A receptor blockade enhances the antipsychotic-like effects of typical antipsychotic drugs, although they do highlight the importance of drug- drug conditioning process in altering drug efficacy in polypharmacy.

Original languageEnglish (US)
Pages (from-to)103-108
Number of pages6
JournalExperimental and Clinical Psychopharmacology
Volume27
Issue number2
DOIs
StatePublished - Apr 2019

Fingerprint

Receptor, Serotonin, 5-HT2A
Antipsychotic Agents
Pharmaceutical Preparations
Serotonin
Polypharmacy
Serotonin Antagonists
Haloperidol
Drug Interactions
Sprague Dawley Rats

Keywords

  • Conditioned avoidance response
  • Drug-drug conditioning
  • Haloperidol
  • MDL100907
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Does Antagonism at 5-HT 2A Receptors Potentiate D2 Blockade-Induced Disruption of Conditioned Avoidance Response? . / Gao, Jun; Huang, Yujing; Li, Ming.

In: Experimental and Clinical Psychopharmacology, Vol. 27, No. 2, 04.2019, p. 103-108.

Research output: Contribution to journalArticle

@article{cb7b567cc96d4faa9cc8d2938b04f4a9,
title = "Does Antagonism at 5-HT 2A Receptors Potentiate D2 Blockade-Induced Disruption of Conditioned Avoidance Response?",
abstract = "Existing evidence in the literature shows that antagonism at 5-HT 2A receptors potentiates D2 antagonisminduced disruption of conditioned avoidance response (CAR), a behavioral index of antipsychotic activity, suggesting that combining 5-HT 2A antagonism with D2 antagonism may confer an enhanced antipsychotic effect. The present study reexamined this issue and further investigated other behavioral effects of drug- drug interaction, mainly the conditioned drug effect (via drug- drug conditioning) and 5-HT 2A antagonism's modulation on antipsychotic-induced sensitization (an enhanced avoidance disruption). Well-trained adult male Sprague-Dawley rats were first repeatedly tested for 7 days under haloperidol (HAL; 0.05 mg/kg, subcutaneous [sc], a typical antipsychotic drug with potent D2 antagonism), MDL100907 (0.5 and 1.0 mg/kg, sc, a selective 5-HT 2A antagonist), combined MDL100907 and HAL, or vehicle control, followed by one challenge test under MDL100907 (0.5 mg/kg) to assess the conditioned drug effect and one challenge test under HAL (0.025 mg/kg) to assess HAL sensitization. Results showed that MDL100907 by itself had no effect on CAR. Importantly, MDL100907 treatment did little to alter the acute and sensitized effects of HAL-induced (0.05 mg/kg, sc) suppression of CAR under various treatment conditions. Repeated pairing of MDL100907 (1.0 mg/kg) with HAL rendered MDL100907 itself to exhibit an {"}acquired{"} CAR disruptive effect through a drug- drug conditioning process. These results do not support the notion that 5-HT 2A receptor blockade enhances the antipsychotic-like effects of typical antipsychotic drugs, although they do highlight the importance of drug- drug conditioning process in altering drug efficacy in polypharmacy.",
keywords = "Conditioned avoidance response, Drug-drug conditioning, Haloperidol, MDL100907, Schizophrenia",
author = "Jun Gao and Yujing Huang and Ming Li",
year = "2019",
month = "4",
doi = "10.1037/pha0000243",
language = "English (US)",
volume = "27",
pages = "103--108",
journal = "Experimental and Clinical Psychopharmacology",
issn = "1064-1297",
publisher = "American Psychological Association Inc.",
number = "2",

}

TY - JOUR

T1 - Does Antagonism at 5-HT 2A Receptors Potentiate D2 Blockade-Induced Disruption of Conditioned Avoidance Response?

AU - Gao, Jun

AU - Huang, Yujing

AU - Li, Ming

PY - 2019/4

Y1 - 2019/4

N2 - Existing evidence in the literature shows that antagonism at 5-HT 2A receptors potentiates D2 antagonisminduced disruption of conditioned avoidance response (CAR), a behavioral index of antipsychotic activity, suggesting that combining 5-HT 2A antagonism with D2 antagonism may confer an enhanced antipsychotic effect. The present study reexamined this issue and further investigated other behavioral effects of drug- drug interaction, mainly the conditioned drug effect (via drug- drug conditioning) and 5-HT 2A antagonism's modulation on antipsychotic-induced sensitization (an enhanced avoidance disruption). Well-trained adult male Sprague-Dawley rats were first repeatedly tested for 7 days under haloperidol (HAL; 0.05 mg/kg, subcutaneous [sc], a typical antipsychotic drug with potent D2 antagonism), MDL100907 (0.5 and 1.0 mg/kg, sc, a selective 5-HT 2A antagonist), combined MDL100907 and HAL, or vehicle control, followed by one challenge test under MDL100907 (0.5 mg/kg) to assess the conditioned drug effect and one challenge test under HAL (0.025 mg/kg) to assess HAL sensitization. Results showed that MDL100907 by itself had no effect on CAR. Importantly, MDL100907 treatment did little to alter the acute and sensitized effects of HAL-induced (0.05 mg/kg, sc) suppression of CAR under various treatment conditions. Repeated pairing of MDL100907 (1.0 mg/kg) with HAL rendered MDL100907 itself to exhibit an "acquired" CAR disruptive effect through a drug- drug conditioning process. These results do not support the notion that 5-HT 2A receptor blockade enhances the antipsychotic-like effects of typical antipsychotic drugs, although they do highlight the importance of drug- drug conditioning process in altering drug efficacy in polypharmacy.

AB - Existing evidence in the literature shows that antagonism at 5-HT 2A receptors potentiates D2 antagonisminduced disruption of conditioned avoidance response (CAR), a behavioral index of antipsychotic activity, suggesting that combining 5-HT 2A antagonism with D2 antagonism may confer an enhanced antipsychotic effect. The present study reexamined this issue and further investigated other behavioral effects of drug- drug interaction, mainly the conditioned drug effect (via drug- drug conditioning) and 5-HT 2A antagonism's modulation on antipsychotic-induced sensitization (an enhanced avoidance disruption). Well-trained adult male Sprague-Dawley rats were first repeatedly tested for 7 days under haloperidol (HAL; 0.05 mg/kg, subcutaneous [sc], a typical antipsychotic drug with potent D2 antagonism), MDL100907 (0.5 and 1.0 mg/kg, sc, a selective 5-HT 2A antagonist), combined MDL100907 and HAL, or vehicle control, followed by one challenge test under MDL100907 (0.5 mg/kg) to assess the conditioned drug effect and one challenge test under HAL (0.025 mg/kg) to assess HAL sensitization. Results showed that MDL100907 by itself had no effect on CAR. Importantly, MDL100907 treatment did little to alter the acute and sensitized effects of HAL-induced (0.05 mg/kg, sc) suppression of CAR under various treatment conditions. Repeated pairing of MDL100907 (1.0 mg/kg) with HAL rendered MDL100907 itself to exhibit an "acquired" CAR disruptive effect through a drug- drug conditioning process. These results do not support the notion that 5-HT 2A receptor blockade enhances the antipsychotic-like effects of typical antipsychotic drugs, although they do highlight the importance of drug- drug conditioning process in altering drug efficacy in polypharmacy.

KW - Conditioned avoidance response

KW - Drug-drug conditioning

KW - Haloperidol

KW - MDL100907

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=85058848326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058848326&partnerID=8YFLogxK

U2 - 10.1037/pha0000243

DO - 10.1037/pha0000243

M3 - Article

C2 - 30556732

AN - SCOPUS:85058848326

VL - 27

SP - 103

EP - 108

JO - Experimental and Clinical Psychopharmacology

JF - Experimental and Clinical Psychopharmacology

SN - 1064-1297

IS - 2

ER -